REIT - Residential
Compare Stocks
2 / 10Stock Comparison
VRE vs CPT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
VRE vs CPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Residential | REIT - Residential |
| Market Cap | $1.78B | $10.98B |
| Revenue (TTM) | $291M | $1.18B |
| Net Income (TTM) | $70M | $388M |
| Gross Margin | 23.4% | 61.3% |
| Operating Margin | 14.7% | 18.1% |
| Forward P/E | 23.7x | 68.4x |
| Total Debt | $1.37B | $3.90B |
| Cash & Equiv. | $14M | $25M |
VRE vs CPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Veris Residential, … (VRE) | 100 | 124.6 | +24.6% |
| Camden Property Tru… (CPT) | 100 | 114.5 | +14.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRE vs CPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 6.4%, EPS growth 420.0%, 3Y rev CAGR 7.3%
- Lower volatility, beta 0.22, current ratio 0.08x
- 6.4% FFO/revenue growth vs CPT's 1.9%
CPT is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.36, yield 4.1%
- 68.5% 10Y total return vs VRE's -12.8%
- Beta 0.36, yield 4.1%, current ratio 0.10x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% FFO/revenue growth vs CPT's 1.9% | |
| Value | Lower P/E (23.7x vs 68.4x) | |
| Quality / Margins | 32.8% margin vs VRE's 24.2% | |
| Stability / Safety | Beta 0.22 vs CPT's 0.36 | |
| Dividends | 4.1% yield, 4-year raise streak, vs VRE's 1.7% | |
| Momentum (1Y) | +21.7% vs CPT's -8.4% | |
| Efficiency (ROA) | 4.3% ROA vs VRE's 2.5%, ROIC 2.6% vs 1.3% |
VRE vs CPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRE vs CPT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CPT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CPT is the larger business by revenue, generating $1.2B annually — 4.1x VRE's $291M. CPT is the more profitable business, keeping 32.8% of every revenue dollar as net income compared to VRE's 24.2%. On growth, VRE holds the edge at +3.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $291M | $1.2B |
| EBITDAEarnings before interest/tax | $129M | $867M |
| Net IncomeAfter-tax profit | $70M | $388M |
| Free Cash FlowCash after capex | $50M | $714M |
| Gross MarginGross profit ÷ Revenue | +23.4% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +18.1% |
| Net MarginNet income ÷ Revenue | +24.2% | +32.8% |
| FCF MarginFCF ÷ Revenue | +17.1% | +60.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.5% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.4% | +11.1% |
Valuation Metrics
VRE leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, VRE trades at a 20% valuation discount to CPT's 29.6x P/E. On an enterprise value basis, CPT's 16.5x EV/EBITDA is more attractive than VRE's 23.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.8B | $11.0B |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $14.9B |
| Trailing P/EPrice ÷ TTM EPS | 23.69x | 29.61x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 68.43x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.27x |
| EV / EBITDAEnterprise value multiple | 23.08x | 16.51x |
| Price / SalesMarket cap ÷ Revenue | 6.17x | 6.98x |
| Price / BookPrice ÷ Book value/share | 1.52x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 32.35x | 28.42x |
Profitability & Efficiency
CPT leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
CPT delivers a 8.7% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $6 for VRE. CPT carries lower financial leverage with a 0.88x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRE's 1.07x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +8.7% |
| ROA (TTM)Return on assets | +2.5% | +4.3% |
| ROICReturn on invested capital | +1.3% | +2.6% |
| ROCEReturn on capital employed | +2.0% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.07x | 0.88x |
| Net DebtTotal debt minus cash | $1.4B | $3.9B |
| Cash & Equiv.Liquid assets | $14M | $25M |
| Total DebtShort + long-term debt | $1.4B | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | 1.84x | 3.89x |
Total Returns (Dividends Reinvested)
VRE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VRE five years ago would be worth $11,436 today (with dividends reinvested), compared to $10,289 for CPT. Over the past 12 months, VRE leads with a +21.7% total return vs CPT's -8.4%. The 3-year compound annual growth rate (CAGR) favors VRE at 6.7% vs CPT's 1.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +28.2% | -3.9% |
| 1-Year ReturnPast 12 months | +21.7% | -8.4% |
| 3-Year ReturnCumulative with dividends | +21.4% | +5.7% |
| 5-Year ReturnCumulative with dividends | +14.4% | +2.9% |
| 10-Year ReturnCumulative with dividends | -12.8% | +68.5% |
| CAGR (3Y)Annualised 3-year return | +6.7% | +1.9% |
Risk & Volatility
VRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VRE is the less volatile stock with a 0.22 beta — it tends to amplify market swings less than CPT's 0.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRE currently trades 99.6% from its 52-week high vs CPT's 87.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | 0.36x |
| 52-Week HighHighest price in past year | $19.03 | $120.15 |
| 52-Week LowLowest price in past year | $13.69 | $96.53 |
| % of 52W HighCurrent price vs 52-week peak | +99.6% | +87.2% |
| RSI (14)Momentum oscillator 0–100 | 65.1 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 982K |
Analyst Outlook
CPT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates VRE as "Hold" and CPT as "Hold". Consensus price targets imply 7.3% upside for CPT (target: $112) vs -26.1% for VRE (target: $14). For income investors, CPT offers the higher dividend yield at 4.06% vs VRE's 1.70%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $14.00 | $112.48 |
| # AnalystsCovering analysts | 12 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.7% | +4.1% |
| Dividend StreakConsecutive years of raises | 3 | 4 |
| Dividend / ShareAnnual DPS | $0.32 | $4.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +2.5% |
CPT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VRE leads in 3 (Valuation Metrics, Total Returns).
VRE vs CPT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is VRE or CPT a better buy right now?
For growth investors, Veris Residential, Inc.
(VRE) is the stronger pick with 6. 4% revenue growth year-over-year, versus 1. 9% for Camden Property Trust (CPT). Veris Residential, Inc. (VRE) offers the better valuation at 23. 7x trailing P/E, making it the more compelling value choice. Analysts rate Veris Residential, Inc. (VRE) a "Hold" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRE or CPT?
On trailing P/E, Veris Residential, Inc.
(VRE) is the cheapest at 23. 7x versus Camden Property Trust at 29. 6x.
03Which is the better long-term investment — VRE or CPT?
Over the past 5 years, Veris Residential, Inc.
(VRE) delivered a total return of +14. 4%, compared to +2. 9% for Camden Property Trust (CPT). Over 10 years, the gap is even starker: CPT returned +68. 5% versus VRE's -12. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRE or CPT?
By beta (market sensitivity over 5 years), Veris Residential, Inc.
(VRE) is the lower-risk stock at 0. 22β versus Camden Property Trust's 0. 36β — meaning CPT is approximately 63% more volatile than VRE relative to the S&P 500. On balance sheet safety, Camden Property Trust (CPT) carries a lower debt/equity ratio of 88% versus 107% for Veris Residential, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRE or CPT?
By revenue growth (latest reported year), Veris Residential, Inc.
(VRE) is pulling ahead at 6. 4% versus 1. 9% for Camden Property Trust (CPT). On earnings-per-share growth, the picture is similar: Veris Residential, Inc. grew EPS 420. 0% year-over-year, compared to 136. 0% for Camden Property Trust. Over a 3-year CAGR, VRE leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRE or CPT?
Veris Residential, Inc.
(VRE) is the more profitable company, earning 26. 1% net margin versus 24. 4% for Camden Property Trust — meaning it keeps 26. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CPT leads at 18. 4% versus 17. 1% for VRE. At the gross margin level — before operating expenses — CPT leads at 61. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRE or CPT more undervalued right now?
Analyst consensus price targets imply the most upside for CPT: 7.
3% to $112. 48.
08Which pays a better dividend — VRE or CPT?
All stocks in this comparison pay dividends.
Camden Property Trust (CPT) offers the highest yield at 4. 1%, versus 1. 7% for Veris Residential, Inc. (VRE).
09Is VRE or CPT better for a retirement portfolio?
For long-horizon retirement investors, Veris Residential, Inc.
(VRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 22), 1. 7% yield). Both have compounded well over 10 years (VRE: -12. 8%, CPT: +68. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRE and CPT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VRE is a small-cap quality compounder stock; CPT is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.